Actualités

The potential and benefits of repurposing existing drugs to treat rare muscular dystrophies

Hesham M. Ismail, Olivier M. Dorchies & Leonardo Scapozza Expert Opinion on Orphan Drugs, DOI: 10.1080/21678707.2018.1452733

27 mars 2018

Autologous Cell Therapy Approach for Duchenne Muscular Dystrophy using PiggyBac Transposons and Mesoangioblasts.

Iyer PS, Mavoungou LO, Ronzoni F, Zemla J, Schmid-Siegert E, Antonini S, Neff LA, Dorchies OM, Jaconi M, Lekka M, Messina G, Mermod N. Mol Ther. 2018 Feb 2 pii:...

13 mars 2018

Congenital myopathies: disorders of excitation-contraction coupling and muscle contraction.

Jungbluth H, Treves S, Zorzato F, Sarkozy A, Ochala J, Sewry C, Phadke R, Gautel M, Muntoni F. Nat Rev Neurol. 2018 Mar;14(3):151-167.

01 mars 2018

Increasing Agrin Function Antagonizes Muscle Atrophy and Motor Impairment in Spinal Muscular Atrophy.

Boido M, De Amicis E, Valsecchi V, Trevisan M, Ala U, Ruegg MA, Hettwer S, Vercelli A. Front Cell Neurosci. 2018 Jan 30;12:17.

31 janvier 2018

Over-expression of a retinol dehydrogenase (SRP35/DHRS7C) in skeletal muscle activates mTORC2, enhances glucose metabolism and muscle performance.

Ruiz A, Dror E, Handschin C, Furrer R, Perez-Schindler J, Bachmann C, Treves S, Zorzato F. Sci Rep. 2018 Jan 12;8(1)

15 janvier 2018

Determinants, analysis and interpretation of the muscle compound action potential (M wave) in humans: implications for the study of muscle fatigue.

Rodriguez-Falces J, Place N. Eur J Appl Physiol. 2017 Dec 28.

10 janvier 2018

An unbiased silencing screen in muscle cells identifies miR-320a, miR-150, miR-196b, and miR-34c as regulators of skeletal muscle mitochondrial metabolism.

Dahlmans D, Houzelle A, Andreux P, Jörgensen JA, Wang X, de Windt LJ, Schrauwen P, Auwerx J, Hoeks J. Mol Metab. 2017 Nov;6(11):1429-1442.

14 novembre 2017

<< First < Précédent 181-190 191-200 201-210211-220221-230 231-240 241-250 Suivant >Last >>

Actualités

The potential and benefits of repurposing existing drugs to treat rare muscular dystrophies

Autologous Cell Therapy Approach for Duchenne Muscular Dystrophy using PiggyBac Transposons and Mesoangioblasts.

Congenital myopathies: disorders of excitation-contraction coupling and muscle contraction.

Increasing Agrin Function Antagonizes Muscle Atrophy and Motor Impairment in Spinal Muscular Atrophy.

Over-expression of a retinol dehydrogenase (SRP35/DHRS7C) in skeletal muscle activates mTORC2, enhances glucose metabolism and muscle performance.

Determinants, analysis and interpretation of the muscle compound action potential (M wave) in humans: implications for the study of muscle fatigue.

Plasticity of the Muscle Stem Cell Microenvironment

Short vs. long pulses for testing knee extensor neuromuscular properties: does it matter?

Laminin-deficient muscular dystrophy: Molecular pathogenesis and structural repair strategies.

An unbiased silencing screen in muscle cells identifies miR-320a, miR-150, miR-196b, and miR-34c as regulators of skeletal muscle mitochondrial metabolism.

La Fondation

FSRMM